RESUMO
AIM: Allopurinol is widely used as an effective urate-lowering drug and is one of the most frequent causes of cutaneous adverse drug reactions (cADRs). Recently, a strong association of HLA-B*58:01 with allopurinol-induced severe cADRs was identified. This study investigated the predisposition to different types of allopurinol-cADRs conferred by HLA-B*5801 in a Han population from mainland China. PATIENTS & METHODS: HLA-B genotyping was performed on 38 Chinese patients with different types of allopurinol-cADRs from 2008 to 2011. RESULTS: All the allopurinol-cADR patients carried HLA-B*58:01, in contrast with only 11.11% (7/63) in the allopurinol-tolerant patients (odds ratio [OR] = 580.07; p < 0.0001) and 13.99% (80/572) in a Han Chinese population from the human MHC database (dbMHC; OR: 471.09; p < 0.0001) carried the genotype. Each type of allopurinol cADRs revealed a statistically significant association with HLA-B*58:01. In particular, the risk of allopurinol-induced maculopapular eruption was significantly higher in patients with HLA-B*58:01 (OR: 339.00; p < 0.0001). CONCLUSION: The strong association of both the mild and severe types of allopurinol cADRs with the HLA-B*58:01 allele were observed. The results indicated that the prospective use of a genetic test of HLA-B*58:01 might reduce the prevalence of allopurinol-induced cADRs. Original submitted 7 March 2012; Revision submitted 21 May 2012.
Assuntos
Alopurinol , Antígenos HLA-B/genética , Síndrome de Stevens-Johnson/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Alelos , Alopurinol/administração & dosagem , Alopurinol/toxicidade , China , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Exantema/induzido quimicamente , Exantema/genética , Feminino , Predisposição Genética para Doença , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Risco , Síndrome de Stevens-Johnson/induzido quimicamenteRESUMO
Recent research has revealed various molecular markers in lung cancer. However, the organizational principles underlying their genetic regulatory networks still await investigation. Here we performed Network Component Analysis (NCA) and Pathway Crosstalk Analysis (PCA) to construct a regulatory network in human lung cancer (A549) cells which were treated with 50 uM motexafin gadolinium (MGd), a metal cation-containing chemotherapeutic drug for 4, 12, and 24 hours. We identified a set of key TFs, known target genes for these TFs, and signaling pathways involved in regulatory networks. Our work showed that putative interactions between these TFs (such as ESR1/Sp1, E2F1/Sp1, c-MYC-ESR, Smad3/c-Myc, and NFKB1/RELA), between TFs and their target genes (such as BMP41/Est1, TSC2/Myc, APE1/Sp1/p53, RARA/HOXA1, and SP1/USF2), and between signaling pathways (such as PPAR signaling pathway and Adipocytokines signaling pathway). These results will provide insights into the regulatory mechanism of MGd-treated human lung cancer cells.
Assuntos
Antineoplásicos/farmacologia , Biologia Computacional , Redes Reguladoras de Genes/efeitos dos fármacos , Neoplasias Pulmonares/tratamento farmacológico , Metaloporfirinas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Transcrição Gênica/efeitos dos fármacos , Linhagem Celular Tumoral , Redes Reguladoras de Genes/genética , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patologia , Fatores de Transcrição/metabolismoRESUMO
Evidence suggests that the human histamine H3 receptor (HRH3) may be involved in the pharmacodynamics of risperidone and influence clinical efficacy. More information on the pharmacogenetics of this receptor may therefore be useful in developing individualized therapy. However, to our knowledge, no study has been reported in this area. The aim of this investigation was to clarify whether H3 receptor polymorphism could affect risperidone efficacy. We genotyped tag single nucleotide polymorphisms (SNPs) of the HRH3 gene (rs3787429 and rs3787430) and analyzed their association with the reduction of Brief Psychiatric Rating Scale (BPRS) score in Chinese Han schizophrenia patients (N = 129), following an eight-week period of risperidone monotherapy. The confounding effects of non-genetic factors were estimated, and then the significant one was included as the covariate for adjustment in statistical analysis. Baseline symptom score was the only significant confounding effect and thus the covariate. After adjustment, significant association of HRH3 with antipsychotic efficacy was detected (for rs3787429, p = 0.013, 0.087 after 4 weeks and 8 weeks of treatment, respectively; for rs3787430, p = 0.024, 0.010 after 4 weeks and 8 weeks of treatment, respectively) and stood up to conservative Bonferroni correction. Our results demonstrate that polymorphism of the HRH3 gene may be a potential genetic marker for predicting the therapeutic effect of risperidone, and suggest novel pharmacological links between HRH3 and risperidone. Further studies with larger samples and different ethnic populations are warranted to confirm our results.
Assuntos
Antipsicóticos/uso terapêutico , Receptores Histamínicos H3/genética , Risperidona/uso terapêutico , Esquizofrenia/tratamento farmacológico , Esquizofrenia/genética , Adulto , Povo Asiático/genética , Escalas de Graduação Psiquiátrica Breve , Feminino , Genótipo , Humanos , Masculino , Farmacogenética/métodos , Polimorfismo de Nucleotídeo ÚnicoRESUMO
OBJECTIVES: Suicidal behavior is a serious public health problem which is partly heritable. Identifying the genes and the neurobiologic pathways relevant to suicidal behavior is important for preventative strategies. One family-based study reported an association between sodium channel voltage gated type VIII alpha (SCN8A) and suicidal behavior. In the present study, we aimed to search for SCN8A polymorphisms conferring genetic susceptibility to suicide in the Chinese population. METHODS: A total of 626 subjects was recruited for the study, including 297 suicide attempters and 329 non-attempters from Shanghai, China. We conducted a case-control association analysis of five SNPs (rs10506302, rs1601012, rs4762004, rs12581041, rs17126078) within the region of SCN8A gene. RESULTS: we found that two genetic polymorphisms showed statistically significant differences between cases and controls (rs1601012, P=0.004; rs12581041, P=0.01). Moreover, no haplotypes were significantly associated with suicidal behavior in psychiatric disorders after the false discovery rate (FDR) correction. In the analysis of schizophrenia subgroup, three genetic polymorphisms showed statistically significant differences between cases and controls (rs10506302, P=0.024; rs1601012, P=0.004; rs12581041, P=0.004). CONCLUSIONS: Our findings suggest that the SCN8A gene may be involved in the susceptibility to suicidal behavior among psychiatric disorder patients in the Han Chinese population.
Assuntos
Alelos , Predisposição Genética para Doença/genética , Transtornos Mentais/genética , Proteínas do Tecido Nervoso/genética , Polimorfismo de Nucleotídeo Único/genética , Canais de Sódio/genética , Tentativa de Suicídio/psicologia , Adulto , Alcoolismo/genética , Alcoolismo/psicologia , Transtornos de Ansiedade/genética , Transtornos de Ansiedade/psicologia , Estudos de Casos e Controles , China , Feminino , Genótipo , Humanos , Masculino , Transtornos Mentais/psicologia , Pessoa de Meia-Idade , Canal de Sódio Disparado por Voltagem NAV1.6 , Transtornos Neurocognitivos/genética , Transtornos Neurocognitivos/psicologia , Transtornos da Personalidade/genética , Transtornos da Personalidade/psicologia , Fatores de Risco , Esquizofrenia/genética , Psicologia do Esquizofrênico , Transtornos Relacionados ao Uso de Substâncias/genética , Transtornos Relacionados ao Uso de Substâncias/psicologiaRESUMO
AIMS: To date, there have been relatively few studies on the UGT1A6 gene in the Chinese population. The present study was designed to determine the allele frequencies and haplotypes of this gene in the population and predict the candidate functional mutations. MATERIALS & METHODS: We carried out the first systematic screening of polymorphisms of the gene in an SNP analysis involving 1074 Chinese subjects from three ethnic groups, namely Han, Dong and She, using direct sequencing. We identified the putative substrate binding pocket using a homology-modeled structure and produced a practical model for predicting the function of polymorphisms in UGT1A6. RESULTS: A total of six SNPs and 10 mutations were detected including nine known and seven novel ones. The novel mutations were 73G>A (V25I), 89T>G (L30R), 222A>C, 657C>A, 773A>T (D258V), 1040A>G (N347S) and 1467C>T. In addition, we detected, for the first time in the Chinese population, SNPs 105C>T, 627G>T as well as mutations 308C>A (S103X), IVS2+15T>C and 1088C>T (P363L). Strong linkage disequilibrium was observed among 19T>G, 315A>G, 541A>G and 552A>C. There were seven haplotypes whose frequencies were more than 0.01 in one or more of the three ethnic groups. P363L in the C-terminal domain might weaken the binding of cofactor UDPGA to the domain and induce a poor metabolism genotype of UGT1A6. CONCLUSION: Our study suggests that genetic polymorphisms in UGT1A6 may contribute to interindividual and intra-ethnic differences. The results should prove helpful in the development of pharmacogenomics in China.
Assuntos
Glucuronosiltransferase/genética , Desequilíbrio de Ligação , Polimorfismo Genético , Polimorfismo de Nucleotídeo Único , Povo Asiático/genética , DNA/genética , DNA/isolamento & purificação , Primers do DNA , Etnicidade/genética , Éxons , Feminino , Frequência do Gene , Glucuronosiltransferase/química , Humanos , Masculino , Modelos Moleculares , Mutação , Farmacogenética/tendências , Reação em Cadeia da Polimerase , Valor Preditivo dos Testes , Conformação ProteicaRESUMO
It is generally considered that iodine deficiency is the single most common cause of preventable mental retardation (MR) and brain damage. The SLC26A4 gene is expressed at the apical surface of thyrocytes and its product forms an efficient iodide-trapping mechanism. To investigate whether variability in the SLC26A4 gene influences the risk of iodine-deficiency based MR, we undertook an association study between SLC26A4 and MR. Participants were recruited from a relatively isolated and traditionally iodine-deficient region with a high prevalence of MR. The SNPs we selected from the dbSNP and HapMap were identified using ARMS-PCR and sequencing methods. Singular-locus and haplotype association analysis indicated no association between the SLC26A4 gene and MR (p>0.05). The negative results suggest that the SLC26A4 gene has no measurable impact on iodine-deficiency based MR. In view of the characteristics of our samples, our study may provide a good reference for research into the transport features of pendrin in the thyrocyte apical surface.